Zubair Muhammad, Adil Khan Muhammad, Khan Muhammad Nasir Ayub, Iqbal Sajida, Ashraf Muhammad, Saleem Salman A
Pain Management, Shifa International Hospital Islamabad, Islamabad, PAK.
Anaesthesiology, Shifa International Hospital Islamabad, Islamabad, PAK.
Cureus. 2022 Mar 14;14(3):e23151. doi: 10.7759/cureus.23151. eCollection 2022 Mar.
Thoracic epidural analgesia (TEA) is commonly used for pain management in donor hepatectomy. Erector spinae plane block (ESPB) is a newer ultrasound-guided block described for the management of thoracic and abdominal pain. There is limited literature available comparing the two techniques. The objective of this study was to compare the postoperative analgesic efficacy and adverse effects of continuous ESPB to continuous TEA in donor hepatectomy.
The randomized controlled trial (RCT) was registered on ClinicalTrials.gov (NCT04151511). A total of 82 patients undergoing donor hepatectomy between January 2020 and December 2020 were recruited, of whom 41 received TEA and 41 received ESPB. Randomization was done by the sealed opaque envelope method.
The mean visual analog scale (VAS) scores in donors who received TEA and ESPB in post-anesthesia care unit (PACU) (2.7 + 0.9 vs. 2.4 + 0.5; P = 0.02) at one hour (2.7 + 0.9 vs. 2.2 + 0.6; P = 0.008), six hours (1.8 + 0.9 vs. 0.8 + 0.5; P < 0.001), 12 hours (0.9 + 0.7 vs. 0.2 + 0.7; P < 0.001), and 24 hours (0.48 + 0.5 vs. 0.08 + 0.3; P < 0.001) were significantly different. Mean opioid consumption was 3.38 ± 6.24 mg in the ESPB group and 10.75 ± 9.64 mg in the TEA group (P < 0.001). Mean lung volume (MLV) at 24 hours in the TEA group and ESPB group was 1543 ml and 1815 ml (P < 0.001). MLV was 2545 ml in the TEA group and 2820 ml in the ESPB group at 48 hours (P < 0.001). Mean nausea and vomiting score at six hours was 0.1 vs. 0.03 (P = 0.02).
ESPB improves pain control after donor hepatectomy with an enhanced safety profile and reduced opioid consumption.
胸段硬膜外镇痛(TEA)常用于供体肝切除术的疼痛管理。竖脊肌平面阻滞(ESPB)是一种用于胸腹部疼痛管理的新型超声引导阻滞技术。比较这两种技术的文献有限。本研究的目的是比较供体肝切除术中持续ESPB与持续TEA的术后镇痛效果及不良反应。
该随机对照试验(RCT)已在ClinicalTrials.gov(NCT04151511)注册。共招募了2020年1月至2020年12月期间接受供体肝切除术的82例患者,其中41例接受TEA,41例接受ESPB。采用密封不透明信封法进行随机分组。
接受TEA和ESPB的供体在麻醉后恢复室(PACU)1小时(2.7 + 0.9 vs. 2.4 + 0.5;P = 0.02)、6小时(2.7 + 0.9 vs. 2.2 + 0.6;P = 0.008)、12小时(0.9 + 0.7 vs. 0.2 + 0.7;P < 0.001)和24小时(0.48 + 0.5 vs. 0.08 + 0.3;P < 0.001)时的平均视觉模拟量表(VAS)评分有显著差异。ESPB组的平均阿片类药物消耗量为3.38±6.24 mg,TEA组为10.75±9.64 mg(P < 0.001)。TEA组和ESPB组在24小时时的平均肺容积(MLV)分别为1543 ml和1815 ml(P < 0.001)。48小时时,TEA组的MLV为2545 ml,ESPB组为2820 ml(P < 0.001)。6小时时的平均恶心呕吐评分为0.1 vs. 0.03(P = 0.02)。
ESPB可改善供体肝切除术后的疼痛控制,安全性更高,阿片类药物消耗量减少。